TripleTree: credited tech M&A deals
Deals in the ProCloser Tech & SaaS M&A Deal Index where TripleTree was named as an advisor in a public source. Back to the advisor league.
TripleTree is an M&A advisory firm publicly credited on 3 deals in the ProCloser Tech M&A Deal Index (1 sell-side, 2 buy-side), announced between Jul 1, 2026 and Sep 9, 2026.
Sectors: Healthtech (2), SaaS (1). 0 of 3 credited deals disclosed a value.
Last updated Oct 23, 2026.
TripleTree sits at #21 of 163 (tied with 10 other firms) in the advisor league by credited deals, while the median firm in the league holds 1 credited deal. Ties share the better rank. The targets in TripleTree's record, oldest first, are Exdion Healthcare, Outcomes One and Accumulus Technologies. The first credit in TripleTree's record is Exdion Healthcare on Jul 1, 2026 and the latest is Accumulus Technologies on Sep 9, 2026, a span of 70 days. That works out to one credited deal every 35 days on average, and the longest quiet stretch was 64 days between Exdion Healthcare and Outcomes One. The sections below walk through each of those deals, the buyers and co-advisors involved, and how TripleTree compares inside every sector it is credited in, all computed from the rows of the index.
Credited deals
Where TripleTree advised the buyer, the credit appears as "Buy-side" beneath the sell-side advisor cell. Values only where publicly disclosed; every row links to its source.
| Date | Target | Acquirer | Buyer type | Sector | Geo (target → acquirer) | Value | Sell-side advisor | Source |
|---|---|---|---|---|---|---|---|---|
| Accumulus Technologieslife sciences regulatory compliance platform | Eir Partners | Private equity | Healthtech | n/a → n/a | Undisclosed | EP SecuritiesBuy-side: TripleTree | News | |
| Outcomes Onepharmacy management software | H.I.G. Capital | Private equity | Healthtech | US → n/a | Undisclosed | TripleTreeBuy-side: William Blair Preferred | News | |
| Exdion HealthcareAI-driven medical billing and RCM software | Experity | PE-backed strategic | SaaS | n/a → US | Undisclosed | Not disclosedBuy-side: TripleTree | Press release |
Firms in gold are ProCloser preferred firms: each is ranked #1 in one of our best-advisor guides. Other advisors are named as credited in the source. Source links open the original announcement. Credits for TripleTree appear only where TripleTree was named in a public announcement.
TripleTree, deal by deal, newest first
One paragraph for each of the 3 deals credited to TripleTree, written from the fields of the row and the linked source. A clause appears only when the index holds that field.
Eir Partners acquires Accumulus Technologies (buy-side, Sep 9, 2026)
TripleTree is credited as buy-side advisor on this deal, which means TripleTree advised Eir Partners on the purchase of Accumulus Technologies. Eir Partners acquired Accumulus Technologies, a life sciences regulatory platform, for undisclosed terms. The announcement TripleTree was credited on is dated Sep 9, 2026, and the index files Accumulus Technologies under Healthtech in the sub-sector of life sciences regulatory compliance platform. In TripleTree's record the tags attached to Accumulus Technologies are life sciences, regulatory and compliance software. The index classes Eir Partners as a private equity buyer. No price was disclosed for Accumulus Technologies, and the index leaves the figure blank. EP Securities advised the other side of the table from TripleTree. In the date order of TripleTree's own record this is credit 3 of 3, announced 6 days after the Outcomes One credit, and credit 2 of 2 in Healthtech. The announcement behind the Accumulus Technologies credit: Eir Partners acquires life sciences regulatory platform Accumulus Technologies, pehub.com (news). The index rates this row medium confidence.
H.I.G. Capital acquires Outcomes One (sell-side, Sep 3, 2026)
TripleTree is credited as sell-side advisor on this deal, which means TripleTree advised Outcomes One on the sale to H.I.G. Capital. H.I.G. Capital acquired Outcomes One, an Orlando-based pharmacy management software provider, for undisclosed terms. The announcement TripleTree was credited on is dated Sep 3, 2026, and the index files Outcomes One under Healthtech in the sub-sector of pharmacy management software. In TripleTree's record the tags attached to Outcomes One are pharmacy management, healthtech, clinical data and software. The index classes H.I.G. Capital as a private equity buyer. Outcomes One is based in the United States; the index records no buyer country. No price was disclosed for Outcomes One, so no figure is entered for it. William Blair advised the other side of the table from TripleTree. In the date order of TripleTree's own record this is credit 2 of 3, announced 64 days after the Exdion Healthcare credit, and credit 1 of 2 in Healthtech. The announcement behind the Outcomes One credit: Orlando health-tech firm Outcomes acquired by H.I.G. Capital, The Business Journals (news). The index rates this row medium confidence.
Experity acquires Exdion Healthcare (buy-side, Jul 1, 2026)
TripleTree is credited as buy-side advisor on this deal, which means TripleTree advised Experity on the purchase of Exdion Healthcare. Experity acquired Exdion Healthcare, an AI-driven revenue cycle management and medical billing SaaS company, for undisclosed terms. The announcement TripleTree was credited on is dated Jul 1, 2026, and the index files Exdion Healthcare under SaaS in the sub-sector of AI-driven medical billing and RCM software. In TripleTree's record the tags attached to Exdion Healthcare are revenue cycle management, medical billing, coding automation, urgent care and healthcare saas. The index classes Experity as a PE-backed strategic buyer. Experity is based in the United States; the index records no target country. No price was disclosed for Exdion Healthcare, and the index never estimates one. The source names no advisor other than TripleTree on the Exdion Healthcare deal. In the date order of TripleTree's own record this is credit 1 of 3, the earliest credit, and the only SaaS credit for TripleTree. The announcement behind the Exdion Healthcare credit: Experity Acquires Exdion Healthcare to Accelerate AI-Driven Revenue Cycle Management Automation for On-Demand Care, PR Newswire (press release). The index rates this row high confidence.
TripleTree in charts
TripleTree: deals by sector
Data table
| Sector | TripleTree deals (share) |
|---|---|
| Healthtech | 2 (67%) |
| SaaS | 1 (33%) |
TripleTree: deals by buyer type
Data table
| Buyer type | TripleTree deals (share) |
|---|---|
| Private equity | 2 (67%) |
| PE-backed strategic | 1 (33%) |
Who TripleTree worked with
Co-advisors
2 of the 3 deals credited to TripleTree name at least one other advisor, and the other 1 names TripleTree alone. 2 other firms appear next to TripleTree: 0 on the same side and 2 across the table. EP Securities is the most frequent counterpart, sharing 1 deal with TripleTree.
| Firm | With TripleTree on one side | Across the table from TripleTree | Shared deals |
|---|---|---|---|
| EP Securities | 0 | 1 | Accumulus Technologies |
| William Blair | 0 | 1 | Outcomes One |
Acquirers
The 3 deals credited to TripleTree involve 3 distinct acquirers. By buyer type the mix behind TripleTree's deals is private equity (2) and PE-backed strategic (1).
| Acquirer | Buyer type | Deals with TripleTree | Largest disclosed | Targets |
|---|---|---|---|---|
| Eir Partners | Private equity | 1 | Undisclosed | Accumulus Technologies |
| Experity | PE-backed strategic | 1 | Undisclosed | Exdion Healthcare |
| H.I.G. Capital | Private equity | 1 | Undisclosed | Outcomes One |
Sector context for TripleTree
How the credits of TripleTree compare with the whole index in each sector where TripleTree is credited.
Healthtech: TripleTree against the sector
TripleTree is credited on 2 of the 16 advised Healthtech deals, a 12% share, which puts TripleTree #1 of 19 (tied with 3 other firms) among Healthtech advisors. Behind that share, the index tracks 129 Healthtech deals in all, and 16 of them (12%) name an advisor.
TripleTree's Healthtech credits are Accumulus Technologies (Eir Partners, Sep 9, 2026, Undisclosed); Outcomes One (H.I.G. Capital, Sep 3, 2026, Undisclosed).
For the full Healthtech picture beyond TripleTree, see Healthtech sector record (JSON).
SaaS: TripleTree against the sector
TripleTree is credited on 1 of the 59 advised SaaS deals, a 1.7% share, which puts TripleTree #19 of 63 (tied with 44 other firms) among SaaS advisors. Behind that share, the index tracks 442 SaaS deals in all, and 59 of them (13%) name an advisor.
TripleTree's SaaS credits are Exdion Healthcare (Experity, Jul 1, 2026, Undisclosed).
For the full SaaS picture beyond TripleTree, see SaaS M&A Deals (2026) and SaaS sector record (JSON).
What TripleTree's targets look like
The businesses TripleTree advised on are described in the index as life sciences regulatory compliance platform, pharmacy management software and AI-driven medical billing and RCM software.
Across TripleTree's 3 credited rows the tags that recur most are clinical data, coding automation, compliance software, healthcare saas, healthtech, life sciences, medical billing and pharmacy management.
Target countries recorded for TripleTree's deals: the United States (1), known for 1 of 3 rows.
Buyer countries recorded for TripleTree's deals: the United States (1), known for 1 of 3 rows.
0 deals in TripleTree's record are flagged cross-border.
Advisors related to TripleTree
Firms credited in the most of the same sectors as TripleTree, nearest in credited-deal count first. Names link to a profile only where the firm has one.
- William Blair: 2 sectors in common with TripleTree (Healthtech and SaaS), 5 credited deals against 3 for TripleTree
- KPMG: 2 sectors in common with TripleTree (Healthtech and SaaS), 6 credited deals against 3 for TripleTree
- BofA Securities: 2 sectors in common with TripleTree (Healthtech and SaaS), 6 credited deals against 3 for TripleTree
- Houlihan Lokey: 2 sectors in common with TripleTree (Healthtech and SaaS), 8 credited deals against 3 for TripleTree
- Evercore: 2 sectors in common with TripleTree (Healthtech and SaaS), 9 credited deals against 3 for TripleTree
Machine-readable record for TripleTree
The same credits as structured data, with an evidence label on every row: JSON record and Markdown record. Both are licensed CC BY 4.0 and rebuilt daily with this page.
Frequently asked questions about TripleTree
How many deals is TripleTree credited on in this index?
TripleTree is credited on 3 deals: 1 sell-side and 2 buy-side, announced between Jul 1, 2026 and Sep 9, 2026. The targets are Exdion Healthcare, Outcomes One and Accumulus Technologies. 0 of the 3 disclosed a price. That count covers only deals verified by the ProCloser index, each with a public source naming TripleTree, and is not the firm's full track record.
Which sectors does TripleTree advise in?
TripleTree is credited in Healthtech (2) and SaaS (1). Healthtech is the largest at 2 of 3 credited deals (67%). The index tracks 11 sectors in total, so TripleTree appears in 2 of them.
What is the largest deal TripleTree was credited on?
No deal credited to TripleTree disclosed a price, so there is no largest disclosed value to report for TripleTree. Undisclosed prices stay undisclosed in the index and are never estimated.
Is TripleTree mostly a sell-side or a buy-side advisor?
TripleTree is sell-side on 1 of 3 credited deals (33%) and buy-side on 2 (67%). Across all 340 credits in the index, 59% are sell-side, so TripleTree is less sell-side heavy than the league as a whole.
Which acquirers has TripleTree worked with?
TripleTree has worked on deals involving 3 acquirers. The most frequent in TripleTree's record: Eir Partners (1), Experity (1) and H.I.G. Capital (1). Buyer types: private equity (2) and PE-backed strategic (1).
How does TripleTree rank against the typical advisor in the league table?
TripleTree is #21 of 163 (tied with 10 other firms) by credited deals, against a league median of 1 credited deal. TripleTree has no disclosed value to rank. Rankings reflect public credits in this index only and undercount firms that rarely announce their deals.
Where does the data on TripleTree come from?
Each of the 3 credits for TripleTree links to a public source, split by type as news (2) and press release (1). A firm is credited only when its name appears in that source text; we do not add credits for TripleTree from memory or from third-party databases.
Which firms advised alongside TripleTree?
2 other firms appear on the same deals as TripleTree, led by EP Securities (1) and William Blair (1). 2 of 3 deals credited to TripleTree name another advisor.
How do I get an introduction to a firm like TripleTree?
If you are selling a Healthtech company or another software business, get matched and ProCloser will introduce you to a vetted M&A advisory firm that fits your sector and deal size, free to sellers. TripleTree is one of 163 firms credited in the index and ranks #21 of 163 (tied with 10 other firms) by credited deals.
Get matched with the right advisor for your deal.
The advisors credited in this index work deals like yours every quarter. Tell us about your company and we will match you with a vetted M&A advisory firm in your sector and size range, including success-fee-only options. Free to sellers.